Therapy development updates
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Search results
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Monday 26 January 2026, 7.00pm - 8.30pm - via Zoom - Come and join Martik and the group for our first Young Adults online social catch up of 2026.
Wednesday 28 January 2026, 7.00pm - 8.00pm - via Zoom - Come and join us for our first meeting of the year where our host Mark Baxter will be sharing some information from the Visionary panel session - 'Unlocking the Potential of A.I Wearable Technology'.
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.
Giving a regular monthly or quarterly donation of any amount is a wonderful way to help Retina UK support the inherited sight loss community.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Tuesday 20 January 2026, 7.00pm - 8.30pm - via Zoom - Come and join us for our first Men's Peer Support Group online social catch up of the year.
We are delighted to welcome Kathy Evans as our new Chair of Trustees.